Manipulating non-coding RNA regulation to generate breakthrough medicines


About UsAbout Lepton

Lepton Pharmaceuticals Inc. focuses on subtle and precise silencing/suppression of coding RNA expression by small non-coding RNA molecules working via the DROSHA/DICER/RISC pathways, small interfering RNA (siRNA), and microRNA (miRNA) to develop therapies for unmet medical needs

Our ProductsLepton’s proprietary breakthrough general platform to manipulate siRNAs & microRNAs